Novavax inventory sinks just after proposed $125 million share sale, convertible debt giving

Shares of COVID-19 vaccine maker Novavax Inc. on Wednesday sank 11% following the business declared a proposed presenting to offer thousands and thousands of its personal debt and inventory. The enterprise stated the proceeds could go towards the worldwide start of its Nuvaxovid COVID vaccine and the repayment or repurchase of some of the $325 million of its convertible financial debt owing in February. Novavax introduced a proposed sale of up to $125 million in stock, and explained it expects to grant the underwriters a 30-working day possibility to acquire up to an additional $18.75 million of its stock. In conjunction with the share providing, Novavax on Wednesday also announced a proposed $125…